Target intelligence / Profile preview

Cell membrane proteins and lipids

Molecular classification
Other
01

Overview

The cell membrane, or plasma membrane, is a fundamental biological structure composed of a phospholipid bilayer and associated proteins that acts as a selective barrier for the cell (StatPearls, 2023). It is essential for maintaining cellular homeostasis, facilitating signal transduction via receptors, and managing the transport of ions and molecules through specialized channels and transporters (Alberts et al., 2002). While the membrane itself is a structural entity, its individual components—such as G protein-coupled receptors, ion channels, and specific lipids like cholesterol—are among the most common targets for therapeutic intervention (Nature Reviews Drug Discovery, 2006). Dysregulation of membrane proteins and lipids is central to the pathogenesis of various conditions, including cancer, where receptor overexpression drives uncontrolled growth, and infectious diseases, where pathogens exploit membrane components for entry (Cooper, 2000). Drugs targeting the membrane range from antibiotics that disrupt lipid integrity to biologics that bind specific surface proteins to modulate immune responses or signaling (Papo & Shai, 2005). Because the membrane is fundamental to all cells, therapeutic strategies must carefully balance efficacy against the risk of non-specific toxicity to healthy tissues (StatPearls, 2023).

Other names
Plasma membraneCell surface componentsLipid bilayerCytoplasmic membrane
02

Mechanism of action

Drugs interact with membrane components through various mechanisms, including physical disruption of the lipid bilayer, formation of transmembrane pores, modulation of membrane fluidity, and high-affinity binding to integral membrane proteins to inhibit signaling or induce antibody-dependent cellular cytotoxicity (Papo & Shai, 2005; StatPearls, 2023).

03

Biological functions

Signal transductionCell-cell communicationIon and molecule transportStructural integrityCell adhesion
04

Disease associations

CancerInfectionNeurodegenerative diseaseCardiovascular diseaseMetabolic disorder
05

Safety considerations

Non-specific membrane disruptionHemolysisOff-target toxicity to healthy tissuesSystemic inflammatory response
06

Interacting drugs

Amphotericin B

5 more in the full profile.

07

Biomarkers

Cluster of differentiation (CD) markersMembrane lipid compositionSurface receptor expression levels

Beyond the preview

Go deeper on Cell membrane proteins and lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membrane proteins and lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call